France · Advertising framework
Email, SMS and direct-message marketing for diagnostic tests and services in France
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Separate diagnostic products from diagnostic services
Legal requirement — paraphrased
IVDR Article 7 prohibits misleading claims for an in vitro diagnostic device. Describe the intended purpose, users and limitations consistently with its conformity documentation. An advertisement for a laboratory consultation also needs the applicable local provider review; the IVDR does not by itself authorise a medical service.
Sources: EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Self-test promotion has a separate ANSM authorisation route
Regulator guidance
The IVD order lists devices intended for self-testing for prior authorisation of public advertising. Professional promotion has a different list, including specified blood-grouping reagents and HIV, HTLV, hepatitis and variant CJD tests. Record whether the advertised item is a self-test product, a professional test or a laboratory service before applying this route.
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Separate B2C consent from the limited B2B route
Regulator guidance
Consumer promotional email generally needs prior consent. The existing-customer exception concerns the same sender’s similar offers after an actual sale or service. Relevant B2B contact has a separate objection-based route. Identify the advertiser and offer a simple opt-out in each message.
Sources: La prospection commerciale par courrier électronique
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Separate promotional and service messages
Editorial recommendation
Review the rules for the actual delivery method: email, SMS and private social messages are not interchangeable. Keep the relevant permission record, accurate sender details and a working suppression process.
Campaign workflow
Diagnostics & Health Testing: prepare the review
Editorial recommendation
Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate a test kit, laboratory service, screening package and medical interpretation.
- State the intended population and explain the limits of a positive or negative result.
- Review both product rules and provider rules when a device is bundled with a clinical service.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Dental communication, the March 2026 pharmacy code and device/IVD authorisation-list routes are now documented. Still verify the exact product classification, reimbursement, current ANSM decision and filing window, other professional codes and the actual influencer arrangement. The March 2026 visa form is evidence of that filing period, not confirmation of later filing dates.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Advertising diagnostic tests and services by email, SMS and direct messages in France requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.
Email, SMS and private platform messages can follow different permission rules. Identify the delivery technology and the recipient relationship, then review the promotional content and withdrawal process separately.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. French health-product and professional communication baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- La prospection commerciale par courrier électronique
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- IVD advertising prior-authorisation list
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in France
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in France.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.